Literature DB >> 7769692

Recombinant type 5 adenoviruses expressing bovine parainfluenza virus type 3 glycoproteins protect Sigmodon hispidus cotton rats from bovine parainfluenza virus type 3 infection.

M M Breker-Klassen1, D Yoo, S K Mittal, S D Sorden, D M Haines, L A Babiuk.   

Abstract

Cotton rats were used to study the replication and pathogenesis of bovine parainfluenza virus type 3 (bPIV3) and to test the efficacy of the F and HN glycoproteins in modulating infection. In vitro cultures of cotton rat lung cells supported the growth of bPIV3 as shown by virus recovery, immunofluorescence, immunoprecipitation, and syncytium induction. Intranasal (i.n.) inoculation of cotton rats with 10(7) PFU resulted in peak recovery of virus after 2 days (8 x 10(4) PFU/g of lung tissue) and significant bronchiolitis with lymphocyte infiltration 5 to 7 days postinfection. Immunohistochemical staining of lungs and trachea demonstrated that virus antigen-positive cells increased in frequency over the course of infection to a maximum on day 5. Serum antibody responses were evaluated by enzyme-linked immunosorbent assays (ELISA), hemagglutination inhibition (HAI), and serum neutralization (SN). Following a single i.n. inoculation, serum antibody levels were 1/40,960, 1/32, and 1/80, as detected by ELISA, HAI, and SN, respectively. When an intramuscular inoculation of 10(7) PFU was administered 10 days prior to the i.n. inoculation, a secondary response which resulted in an ELISA titer of 1/163,000, an HAI titer of 1/640, and an SN titer of 1/512 was induced. IN inoculation of recombinant adenoviruses type 5 containing the bPIV3 F or HN protein or a combination of the two viruses protected cotton rats from bPIV3 challenge. Protection was evaluated serologically by ELISA, HAI, and SN titers, histopathology, immunohistochemistry, and virus recovery.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769692      PMCID: PMC189170          DOI: 10.1128/JVI.69.7.4308-4315.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Monoclonal and polyclonal antibodies for immunohistochemical detection of bovine parainfluenza type 3 virus in frozen and formalin-fixed paraffin-embedded tissues.

Authors:  D M Haines; J C Kendall; B W Remenda; M M Breker-Klassen; E G Clark
Journal:  J Vet Diagn Invest       Date:  1992-10       Impact factor: 1.279

2.  Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity.

Authors:  M K Spriggs; B R Murphy; G A Prince; R A Olmsted; P L Collins
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

3.  Some characteristics of a natural infection by parainfluenza-3 virus in a group of calves.

Authors:  E M Allan; H M Pirie; I E Selman; D R Snodgrass
Journal:  Res Vet Sci       Date:  1978-05       Impact factor: 2.534

4.  The association between serological titers in infectious bovine rhinotracheitis virus, bovine virus diarrhea virus, parainfluenza-3 virus, respiratory syncytial virus and treatment for respiratory disease in Ontario feedlot calves.

Authors:  S W Martin; J G Bohac
Journal:  Can J Vet Res       Date:  1986-07       Impact factor: 1.310

5.  Intramuscular inoculation of live respiratory syncytial virus induces immunity in cotton rats.

Authors:  G A Prince; L Potash; R L Horswood; E Camargo; S C Suffin; R A Johnson; R M Chanock
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

6.  A new animal model for human respiratory tract disease due to adenovirus.

Authors:  D L Pacini; E J Dubovi; W A Clyde
Journal:  J Infect Dis       Date:  1984-07       Impact factor: 5.226

7.  Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease.

Authors:  B R Murphy; A Sotnikov; P R Paradiso; S W Hildreth; A B Jenson; R B Baggs; L Lawrence; J J Zubak; R M Chanock; J A Beeler
Journal:  Vaccine       Date:  1989-12       Impact factor: 3.641

8.  Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats.

Authors:  G A Prince; R L Horswood; R M Chanock
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

9.  Prevalence of antibodies to infectious bovine rhinotracheitis, parainfluenza 3, bovine respiratory syncytial, and bovine viral diarrhea viruses in cattle in Saskatchewan and Alberta.

Authors:  P J Durham; L E Hassard
Journal:  Can Vet J       Date:  1990-12       Impact factor: 1.008

10.  Ultrastructural features of experimental parainfluenza type 3 virus pneumonia in calves.

Authors:  D G Bryson; M S McNulty; R M McCracken; P F Cush
Journal:  J Comp Pathol       Date:  1983-07       Impact factor: 1.311

View more
  5 in total

1.  Comparisons of the F and HN gene sequences of different strains of bovine parainfluenza virus type 3: relationship to phenotype and pathogenicity.

Authors:  M M Breker-Klassen; D Yoo; L A Babiuk
Journal:  Can J Vet Res       Date:  1996-07       Impact factor: 1.310

2.  A hepadnavirus regulatory element enhances expression of a type 2 bovine viral diarrhea virus E2 protein from a bovine herpesvirus 1 vector.

Authors:  Lingshu Wang; Sreekumar Menon; Steven R Bolin; Leonard J Bello
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

3.  Evaluation of porcine reproductive and respiratory syndrome virus replication in laboratory rodents.

Authors:  Paul Rosenfeld; Patricia V Turner; Janet I MacInnes; Eva Nagy; Dongwan Yoo
Journal:  Can J Vet Res       Date:  2009-10       Impact factor: 1.310

Review 4.  Use of adenoviral vectors as veterinary vaccines.

Authors:  T B Ferreira; P M Alves; J G Aunins; M J T Carrondo
Journal:  Gene Ther       Date:  2005-10       Impact factor: 5.250

5.  Optimization of bovine coronavirus hemagglutinin-estrase glycoprotein expression in E3 deleted bovine adenovirus-3.

Authors:  P S Reddy; N Idamakanti; L N Zakhartchouk; L A Babiuk; M Mehtali; S K Tikoo
Journal:  Virus Res       Date:  2000-09       Impact factor: 3.303

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.